|Day Low/High||2.02 / 2.13|
|52 Wk Low/High||1.75 / 4.14|
Shire, Bellicum Pharmaceuticals and Organovo Holdings were among the biotech stock movers in premarket trading on June 22.
Intra-Cellular Therapies, Organovo Holdings and Acorda Therapeutics were among the biotech stock movers in premarket trading on Monday.
Organovo, Endo and Omeros were among the biotech stock moves in premarket trading on Thursday.
The company's shares were up 24% ahead of market's open on an FDA approval.
Organovo also celebrates positive review of Organovo's 3D bioprinted human liver tissue from industry leaders
The companies inked a $250 million deal on Friday that could be worth up to $2 billion, thanks to milestone payments.
Pacira Pharmaceuticals, Clearside Biomedical and Organovo Holdings are among the premarket biotech movers on Wednesday.
Amicus Therapeutics, Nantkwest and Organovo are among the premarket biotech movers on Tuesday.
Investors in Organovo Holdings Inc saw new options begin trading this week, for the August 2017 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
Results demonstrate clinical promise for bioprinted tissues
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.